Blood protein signature for the early diagnosis of Alzheimer disease

M Britschgi, T Wyss-Coray - Archives of neurology, 2009 - jamanetwork.com
Alzheimer disease (AD) has become one of the main health concerns for the elderly
population in the United States. Current treatments target symptoms only, but several
advanced clinical trials are testing new drugs that are potentially disease modifying.
Because AD is still difficult to diagnose in its earliest stages and the disease process is
estimated to start many years before current clinical diagnosis is made, accurate and simple
diagnostic tools are urgently needed. We recently described a blood-based panel of …